Medication info
Bonomore Tablet 20mg (Bazedoxifene Acetate)

Bonomore Tablet 20mg (Bazedoxifene Acetate)

Prescription medicationTabletOral
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tablet
Manufacturer / importer
Alvogen Korea Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201803834 · Approved 2018.09.28 · Insurance code 652606520

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily (as bazedoxifene 20mg), with or without food. If the patient’s intake of calcium and vitamin D from food is insufficient, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use is not recommended in patients with hepatic impairment because the safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Alvogen Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • spinal fractures
View approved original text

This medication is used to treat and prevent osteoporosis in postmenopausal women. It is particularly effective in reducing the incidence of spinal fractures. However, the efficacy for non-vertebral fractures has not yet been clearly established. Therefore, it is primarily recommended for those at high risk of spinal fractures. When used appropriately according to the patient's situation, it helps improve bone health.

How to take

Adult dose

Take 1 tablet once daily (as bazedoxifene 20mg), with or without food. If the patient’s intake of calcium and vitamin D from food is insufficient, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use is not recommended in patients with hepatic impairment because the safety and efficacy of this medicine have not been established.

Precautions

This medication may increase the risk of venous thromboembolism; therefore, it is not recommended for women with a history of or risk factors for deep vein thrombosis, pulmonary embolism, or retinal vein thrombosis. This medication should only be used in postmenopausal women; premenopausal women or those who may become pregnant should not take it. If unexpected uterine bleeding occurs while taking this medication, a healthcare professional should be consulted immediately. Its safety has not been confirmed when used in conjunction with breast cancer patients or medications related to breast cancer, so usage should be avoided. Patients with hypersensitivity to this medication or its components, a history of venous thromboembolism, pregnant or nursing women, those with unexplained uterine bleeding, and those with symptoms of endometrial cancer should not take this medication. Patients with genetic issues such as lactose intolerance should also avoid this medication. Patients with hypertriglyceridemia, severe renal impairment, or liver dysfunction should use this medication with caution, and the use is specifically not recommended for those with liver dysfunction. Drowsiness and visual disturbances may occur when taking this medication, so caution is needed when driving or operating machinery. The potential for drug interactions with this medication is low; however, certain drugs may alter the metabolism of this medication, so a discussion with a physician is advised. Women who are pregnant or may become pregnant should not take this medication, and nursing mothers should also not use it. It is not for use in children, and elderly patients can use it without special dosage adjustment but should consider changes in liver function. There is no specific antidote for overdose; treatment should be based on symptoms. This medication should be stored away from children and kept in its original container. Various adverse reactions such as facial flushing, leg cramps, thrombosis, gastrointestinal disturbances may occur while taking this medication, so consultation with a physician is needed if any abnormal symptoms occur.

Side effects

  • Venous thromboembolism
  • deep vein thrombosis
  • pulmonary embolism
  • retinal vein thrombosis
  • vasodilation
  • facial flushing
  • leg cramps
  • hypersensitivity
  • drowsiness
  • dry mouth
Show 96 more
  • urticaria
  • rash
  • itching
  • muscle cramps
  • peripheral edema
  • elevated triglycerides
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased vision
  • blurred vision
  • photophobia
  • visual field defects
  • visual impairment
  • dry eye syndrome
  • eyelid edema
  • eyelid spasms
  • eye pain
  • eye swelling
  • vomiting
  • gastritis
  • colon polyp
  • belching
  • allergic reaction
  • chest discomfort
  • leg pain
  • fever
  • generalized edema
  • edema
  • facial edema
  • changes in body temperature sensation
  • malaise
  • weakness
  • fatigue
  • insufficient effect
  • dermatitis
  • localized skin reaction
  • increased sweating
  • eczema
  • hair loss
  • back pain
  • joint pain
  • muscle weakness
  • shoulder rotator cuff syndrome
  • headache
  • dizziness
  • pharyngitis
  • pyelonephritis
  • palpitations
  • retinal hemorrhage
  • bradycardia
  • expectoration issues
  • cough
  • asthma
  • shortness of breath
  • laryngitis
  • pleural effusion
  • increased alkaline phosphatase
  • liver cyst
  • hepatocyte damage
  • bile duct stone
  • weight gain
  • hyperlipidemia
  • central obesity
  • dysuria
  • urinary irregularities
  • renal cyst
  • urinary incontinence
  • vaginal bleeding
  • breast congestion
  • insomnia
  • leukocytosis
  • laceration
  • contusion
  • abdominal pain
  • constipation
  • diarrhea
  • indigestion
  • myalgia
  • fracture
  • spinal stenosis
  • positional dizziness
  • cerebral infarction
  • cerebral hemorrhage
  • death
  • fever
  • generalized edema
  • fatigue
  • fracture
  • myalgia
  • shoulder rotator cuff syndrome
  • spinal stenosis
  • cerebral infarction
  • pyelonephritis
  • bradycardia
  • respiratory failure
  • bile duct stone

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is important to store it at a cool temperature below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.